Barely Significant
← all excerpts

Ginsenoside Rg3 Adjunctively Increases the Efficacy of Gefitinib Against NSCLC by Regulating EGFR Copy Number.

Pharmaceuticals (Basel) · 2025 · PMC12300113 · PMID 40732366

1
hedged sentence
closest p
boldest claim

The sentences

showed a trendno p-value reported
The mutated EGFR showed a trend of slightly increased transcript levels but did not show significant trends or differences in protein expression compared with the wild type ( Figure 3 D).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.